Welcome to CDC Stacks | Notice to clinicians : Summary of CDC recommendations for influenza antiviral medications - 25248 | Health Alert Network (HAN)
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Notice to clinicians : Summary of CDC recommendations for influenza antiviral medications
  • Published Date:
    1/15/13
  • Source:
    HAN ; 339
  • Language:
    English
Filetype[PDF - 2.25 MB]


Details:
  • Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
  • Series:
    HAN ; 339
  • Keywords:
  • Description:
    January 15, 2013, 16:00 ET

    CDCHAN-00339

    CDC continues to recommend antiviral medications for treatment of seasonal influenza and annual vaccination as the best tools for prevention.

    Evidence from past influenza seasons and the 2009 H1N1 pandemic has shown that treatment with antiviral medications can have clinical and public health benefit in reducing severe outcomes of influenza when initiated as soon as possible after illness onset.

    Clinical trials and observational data show that early antiviral treatment may do the following:

    • shorten the duration of fever and illness symptoms

    • reduce the risk of complications from influenza (e.g., otitis media in young children, pneumonia, respiratory failure) and death

    • shorten the duration of hospitalization.

    Summary of CDC recommendations for influenza antiviral medications for the 2012-2013 season.

  • Document Type:
    HAN Health Advisory
  • Collection(s):
    Health Alert Network (HAN)
  • Place as Subject:
    gau
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. CDC recommendations for influenza antiviral medications remain unchanged
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    2/9/12
    Source:
    HAN ; 324
    Series:
    HAN ; 324
    Description:
    February 09, 2012, 15:00 EST : CDCHAN-00324-ADV-N : A recent review of randomized clinical trial data for the influenza neuraminidase inhibitor antiviral medications, and two related commentaries, raised questions about the value of antiviral medicat...
    File Type:
    Filetype[PDF - 1.36 MB]
  2. CDC issues interim recommendations for the use of influenza antiviral medications in the setting of Oseltamivir resistance among circulating influenza A (H1N1 ) viruses, 2008-09 influenza season
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    12/19/08
    Source:
    HAN ; 279
    Series:
    HAN ; 279
    Description:
    Friday, December 19, 2008, 11:50 EST (11:50 AM EST) : CDCHAN-00279-2008-12-19-ADV-N : Although influenza activity is low in the United States to date, preliminary data from a limited number of states indicate that the prevalence of influenza A (H1N1)...
    File Type:
    Filetype[PDF - 47.86 KB]
  3. Notice to clinicians: Early reports of pH1N1-associated illnesses for the 2013-14 influenza season
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    12/24/13
    Source:
    HAN ; 359
    Series:
    HAN ; 359
    Description:
    December 24, 2013, 14:30 ET (2:30 PM ET) : CDCHAN-00359 : From November through December 2013, CDC has received a number of reports of severe respiratory illness among young and middle-aged adults, many of whom were infected with : influenza A (H1N1)...
    File Type:
    Filetype[PDF - 2.85 MB]
  4. CDC health update regarding treatment of patients with influenza with antiviral medications
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    January 9, 2015
    Series:
    HAN ; 375
    Description:
    January 9, 2015, 11:00 ET : CDCHAN-00375 : As a follow-up to HAN 00374 (http://emergency.cdc.gov/han/han00374.asp, Dec. 3, 2014), CDC is providing 1) a summary of influenza antiviral drug treatment recommendations, 2) an update about approved treatme...
    File Type:
    Filetype[PDF - 233.96 KB]
  5. Notice to clinicians : Continued vigilance urged for fungal infections among patients who received contaminated steroid injections
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    3/4/13
    Source:
    HAN ; 342
    Series:
    HAN ; 342
    Description:
    March 4, 2013, 16:30 ET (4:30 PM ET) : CDCHAN-00342 : CDC continues to receive new reports of fungal infection among patients who were given injections of : contaminated methylprednisolone acetate (M PA1) from the New England Compounding Center (NECC...
    File Type:
    Filetype[PDF - 2.40 MB]